For: | Ling Q, Wang K, Lu D, Guo HJ, Jiang WS, He XX, Xu X, Zheng SS. Major influence of renal function on hyperlipidemia after living donor liver transplantation. World J Gastroenterol 2012; 18(47): 7033-7039 [PMID: 23323005 DOI: 10.3748/wjg.v18.i47.7033] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i47/7033.htm |
Number | Citing Articles |
1 |
Qiang Wei, Xiao Xu, Chao Wang, Runzhou Zhuang, Li Zhuang, Lin Zhou, Haiyang Xie, Jian Wu, Min Zhang, Yan Shen, Weilin Wang, Shusen Zheng. Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma. Gut and Liver 2016; 10(4): 604 doi: 10.5009/gnl15017
|
2 |
Hai-Tao Huang, Xue-You Zhang, Cheng Zhang, Qi Ling, Shu-Sen Zheng. Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile. World Journal of Gastroenterology 2020; 26(19): 2373 doi: 10.3748/wjg.v26.i19.2373
|
3 |
K. Fujinaga, M. Usui, N. Yamamoto, E. Ishikawa, A. Nakatani, M. Kishiwada, S. Mizuno, H. Sakurai, M. Tabata, S. Isaji. Hypertension and Hepatitis C Virus Infection Are Strong Risk Factors for Developing Late Renal Dysfunction After Living Donor Liver Transplantation: Significance of Renal Biopsy. Transplantation Proceedings 2014; 46(3): 804 doi: 10.1016/j.transproceed.2013.11.103
|
4 |
Hai-Tao Huang, Xue-You Zhang, Cheng Zhang, Qi Ling, Shu-Sen Zheng. Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile. World Journal of Gastroenterology 2020; 26(19): 2374-2387 doi: 10.3748/wjg.v26.i19.2374
|
5 |
Sabine Gebhardt, Maximilian Jara, Maciej Malinowski, Daniel Seehofer, Gero Puhl, Johann Pratschke, Martin Stockmann. Risk Factors of Metabolic Disorders After Liver Transplantation. Transplantation 2015; 99(6): 1243 doi: 10.1097/TP.0000000000000499
|
6 |
Qi Ling, Xiao Xu, Kai Wang, Chao Wang, Penghui Xiang, Xuanyu Zhang, Runzhou Zhuang, Haiyang Xie, Shusen Zheng. Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients. Medicine 2015; 94(35): e1421 doi: 10.1097/MD.0000000000001421
|
7 |
Patrizia Burra, Chiara Becchetti, Giacomo Germani. NAFLD and liver transplantation: Disease burden, current management and future challenges. JHEP Reports 2020; 2(6): 100192 doi: 10.1016/j.jhepr.2020.100192
|
8 |
Jun Zheng, Wei-Lin Wang. Risk factors of metabolic syndrome after liver transplantation. Hepatobiliary & Pancreatic Diseases International 2015; 14(6): 582 doi: 10.1016/S1499-3872(15)60037-6
|
9 |
Chiara Becchetti, Melisa Dirchwolf, Vanessa Banz, Jean-François Dufour. Medical management of metabolic and cardiovascular complications after liver transplantation. World Journal of Gastroenterology 2020; 26(18): 2138-2154 doi: 10.3748/wjg.v26.i18.2138
|
10 |
Yasuyuki Hara, Naoki Kawagishi, Wataru Nakanishi, Kazuaki Tokodai, Chikashi Nakanishi, Shigehito Miyagi, Noriaki Ohuchi. Prevalence and risk factors of obesity, hypertension, dyslipidemia and diabetes mellitus before and after adult living donor liver transplantation. Hepatology Research 2015; 45(7): 764 doi: 10.1111/hepr.12418
|
11 |
T. Matsui, M. Usui, K. Fujinaga, K. Nakatani, Y. Iizawa, H. Kato, A. Tanemura, Y. Murata, Y. Azumi, N. Kuriyama, M. Kishiwada, S. Mizuno, H. Sakurai, S. Isaji. Influence of Angiotensin-converting Enzyme Genetic Polymorphism on Late Renal Dysfunction After Adult-to-adult Living-donor Liver Transplantation. Transplantation Proceedings 2016; 48(4): 1184 doi: 10.1016/j.transproceed.2016.02.014
|
12 |
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management. Clinical and Molecular Hepatology 2023; 29(Suppl): S286 doi: 10.3350/cmh.2022.0392
|